Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Cassava Sciences Q4 2024 GAAP EPS $(0.57) Beats $(0.66) Estimate, $128.6M In Cash And Cash Equivalents

Author: Benzinga Newsdesk | March 03, 2025 08:32am
Cassava Sciences (NASDAQ:SAVA) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.66) by 13.64 percent. This is a 14 percent decrease over losses of $(0.50) per share from the same period last year.

Posted In: SAVA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist